These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2138176)

  • 41. Clinical trial of topical erythromycin in inflammatory acne.
    Prince RA; Busch DA; Hepler CD; Feldick HG
    Drug Intell Clin Pharm; 1981 May; 15(5):372-6. PubMed ID: 6456140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris.
    Morel P; Vienne MP; Beylot C; Bonérandi JJ; Dréno B; Lehucher-Ceyrac D; Slimani S; Dupuy P
    Clin Exp Dermatol; 1999 Sep; 24(5):354-7. PubMed ID: 10564319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
    Tunca M; Akar A; Ozmen I; Erbil H
    Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Sheehan-Dare R; Layton A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G; Holland KT; Nenoff P
    Eur J Dermatol; 2006; 16(1):48-55. PubMed ID: 16436342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nassiri-Kashani M; Tabatabaie H; Ajami M; Habibey R; Shizarpour M; Babakoohi S; Rahshenas M; Firooz A
    J Dermatolog Treat; 2010 May; 21(3):212-6. PubMed ID: 20394495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
    Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
    J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Local acne therapy with erythromycin].
    Schmidt JB; Thurner J; Poitscheck C; Christl E
    Z Hautkr; 1982 Jan; 57(2):69-77. PubMed ID: 6461974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Topical treatment of acne vulgaris with erythromycin and benzoylperoxide (author's transl)].
    Gloor M; Pfahler E; Neumann W; Höffler U; Hoffmann M; Schmidt U
    Z Hautkr; 1982 Jun; 57(12):867-78. PubMed ID: 6214093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS; Callen JP
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allergic contact dermatitis due to diisopropyl sebacate.
    Dooms-Goossens A; De Veylder H; De Boulle K; Maertens M
    Contact Dermatitis; 1986 Sep; 15(3):192. PubMed ID: 2946543
    [No Abstract]   [Full Text] [Related]  

  • 53. [External erythromycin therapy of acne].
    Schmidt JB; Knobler R; Neumann R; Poitschek C
    Z Hautkr; 1983 Dec; 58(24):1754-60. PubMed ID: 6229931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
    Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
    Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100 mg.
    Gold LS; Cruz A; Eichenfield L; Tan J; Jorizzo J; Kerrouche N; Dhuin JC
    Cutis; 2010 Feb; 85(2):94-104. PubMed ID: 20349684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.
    Leyden J; Thiboutot DM; Shalita AR; Webster G; Washenik K; Strober BE; Shupack J
    Arch Dermatol; 2006 May; 142(5):605-12. PubMed ID: 16702498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral zinc sulphate therapy for acne vulgaris.
    Weismann K; Wadskov S; Sondergaard J
    Acta Derm Venereol; 1977; 57(4):357-60. PubMed ID: 70931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.
    Kircik LH; Baldwin H; Lain E; Guenin E; Harris S; Bhatt V
    J Drugs Dermatol; 2019 Feb; 18(2):178-188. PubMed ID: 30811141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.